rs192289289

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006073.4(TRDN):​c.403G>A​(p.Glu135Lys) variant causes a missense change. The variant allele was found at a frequency of 0.01 in 1,458,352 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E135E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0085 ( 6 hom., cov: 32)
Exomes 𝑓: 0.010 ( 82 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

9
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.76

Publications

10 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008121401).
BP6
Variant 6-123547361-C-T is Benign according to our data. Variant chr6-123547361-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00849 (1289/151898) while in subpopulation NFE AF = 0.0148 (1005/67906). AF 95% confidence interval is 0.014. There are 6 homozygotes in GnomAd4. There are 580 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.403G>A p.Glu135Lys missense_variant Exon 4 of 41 ENST00000334268.9 NP_006064.2 Q13061-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.403G>A p.Glu135Lys missense_variant Exon 4 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1

Frequencies

GnomAD3 genomes
AF:
0.00849
AC:
1289
AN:
151780
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00285
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00440
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00674
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.00719
GnomAD2 exomes
AF:
0.00692
AC:
782
AN:
113040
AF XY:
0.00690
show subpopulations
Gnomad AFR exome
AF:
0.00272
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.000435
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00790
Gnomad NFE exome
AF:
0.0119
Gnomad OTH exome
AF:
0.00695
GnomAD4 exome
AF:
0.0102
AC:
13360
AN:
1306454
Hom.:
82
Cov.:
24
AF XY:
0.00992
AC XY:
6382
AN XY:
643240
show subpopulations
African (AFR)
AF:
0.00165
AC:
45
AN:
27244
American (AMR)
AF:
0.00163
AC:
38
AN:
23350
Ashkenazi Jewish (ASJ)
AF:
0.000388
AC:
9
AN:
23192
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32766
South Asian (SAS)
AF:
0.00155
AC:
97
AN:
62666
European-Finnish (FIN)
AF:
0.00818
AC:
394
AN:
48152
Middle Eastern (MID)
AF:
0.00185
AC:
10
AN:
5416
European-Non Finnish (NFE)
AF:
0.0120
AC:
12377
AN:
1029466
Other (OTH)
AF:
0.00720
AC:
390
AN:
54202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.404
Heterozygous variant carriers
0
497
994
1492
1989
2486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00849
AC:
1289
AN:
151898
Hom.:
6
Cov.:
32
AF XY:
0.00781
AC XY:
580
AN XY:
74224
show subpopulations
African (AFR)
AF:
0.00285
AC:
118
AN:
41460
American (AMR)
AF:
0.00440
AC:
67
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4808
European-Finnish (FIN)
AF:
0.00674
AC:
71
AN:
10534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0148
AC:
1005
AN:
67906
Other (OTH)
AF:
0.00712
AC:
15
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
70
141
211
282
352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
35
Bravo
AF:
0.00763
TwinsUK
AF:
0.0111
AC:
41
ALSPAC
AF:
0.0163
AC:
63
ESP6500AA
AF:
0.00294
AC:
10
ESP6500EA
AF:
0.00991
AC:
76
ExAC
AF:
0.00360
AC:
373
Asia WGS
AF:
0.000584
AC:
2
AN:
3440

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
May 14, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Glu135Lys in exon 4 of TRDN: This variant is not expected to have clinical sig nificance because it has been identified in 1.3% (118/8804) of European chromoso mes including 1 homozygous individual by the Exome Aggregation Consortium (http: //exac.broadinstitute.org/; dbSNP rs192289289). -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 28, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRDN: BS1, BS2 -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Apr 22, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Oct 10, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T;.;.;.
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.88
D;D;D;D
MetaRNN
Benign
0.0081
T;T;T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Uncertain
2.1
M;M;.;M
PhyloP100
3.8
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.1
N;.;N;N
REVEL
Benign
0.25
Sift
Uncertain
0.0070
D;.;D;D
Sift4G
Benign
0.32
T;T;T;T
Polyphen
1.0
D;.;.;.
Vest4
0.29
MVP
0.68
ClinPred
0.0062
T
GERP RS
5.7
Varity_R
0.22
gMVP
0.023
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192289289; hg19: chr6-123868506; COSMIC: COSV99043837; API